Myricetin ameliorates the symptoms of collagen-induced arthritis in mice by inhibiting cathepsin K activity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myricetin ameliorates the symptoms of collagen-induced arthritis in mice by inhibiting cathepsin K activity
Authors
Keywords
-
Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 37, Issue 6, Pages 513-519
Publisher
Informa UK Limited
Online
2015-11-03
DOI
10.3109/08923973.2015.1096942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro
- (2015) Chuanlong Wu et al. BIOCHEMICAL PHARMACOLOGY
- Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells
- (2012) Seon-Yle Ko ARCHIVES OF ORAL BIOLOGY
- Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities
- (2011) Morten A Karsdal et al. ARTHRITIS RESEARCH & THERAPY
- Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
- (2010) M. Neovius et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf
- (2010) Sung Keun Jung et al. BIOCHEMICAL PHARMACOLOGY
- Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves
- (2009) Yan Tong et al. ARCHIVES OF PHARMACAL RESEARCH
- Cathepsin K inhibitors for osteoporosis and potential off-target effects
- (2009) Dieter Brömme et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
- (2009) Beatrix Bartok et al. IMMUNOLOGICAL REVIEWS
- Rheumatoid arthritis
- (2009) Lars Klareskog et al. LANCET
- Akt is a direct target for myricetin to inhibit cell transformation
- (2009) Takuma Kumamoto et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor–transgenic mice
- (2008) Uta Schurigt et al. ARTHRITIS AND RHEUMATISM
- Review: Immune cells and mediators of inflammatory arthritis
- (2008) Georg Schett AUTOIMMUNITY
- MKK4 is a novel target for the inhibition of tumor necrosis factor-α-induced vascular endothelial growth factor expression by myricetin
- (2008) Jong-Eun Kim et al. BIOCHEMICAL PHARMACOLOGY
- The role of proteases in pathologies of the synovial joint
- (2008) G JONES et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Rheumatic Diseases in China
- (2008) Qing Zeng et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More